Oğuzhan BAYDAR, Esin ALPÖZ, Erinç ÖNEM, Veysel BERBER, Dilara OZYİĞİT BÜYÜKTALANCI

Tükürük Bezi Kanalı Karsinomu: Nadir Görülen Bir Olgu Sunumu ve Literatür Taraması

Tükürük bezi kanalı karsinomu (TKK) malign epitelial tükürük bezi tümörlerinden olup sıklıkla parotis bezinde, nadir de olsa minör tükürük bezlerinde gözlenir. Tüm tükürük bezi neoplazmlarının %2’sini oluşturmaktadır. Primer minör TKK tanısında ultrasonografi (USG), bilgisayarlı tomografi (BT), manyetik rezonans görüntüleme (MRG) ve pozitron emisyon tomografisi (PET) sıklıkla kullanılan görüntüleme yöntemleridir, ancak hastalığın kesin tanısında histopatolojik inceleme altın standart olan kabul edilmektedir. Minör TKK olguları çoğunlukla palatinada, daha az sıklıkla dilde, dudakta, bukkal mukozada ve retromolar trigonda lokalizedir. Bu olgu sunumunda, 64 yaşında bir erkek hastada alt çene posterior bukkal mukozada saptanan TKK’nin klinik önemi radyolojik ve histopatolojik bulgular ışığında tartışılmaktadır.

Salivary Gland Ductus Carcinoma: A Rare Case Report and Review of Literature

Salivary duct carcinoma (SDC) is one of the malign epithelial salivary gland tumors. It is frequently observed in parotid gland and rarely in minor salivary glands. It constitutes 2% of all salivary gland neoplasms. Ultrasonography (USG), computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) are frequently used imaging methods in the diagnosis of SDC originating from minor salivary glands. However histopathological examination is considered as the gold standard in the final diagnosis of the lesion. SDC of minor glands cases are mostly localized in the palate, to a lesser extent in the tongue, lips, buccal mucosa and retromolar trigon. In this case report, the clinical importance of SDC localized in posterior buccal mucosa of a 64-year old male patient is discussed in the light of radiological and histopathological findings.

PDF

___

1. de Araújo VC, Kowalski LP, Soares F et al. Salivary duct carcinoma: cytokeratin 14 as a marker of in-situ intraductal growth. Histopathology. 2002;41:244–9.
2. van Heerden WFP, Raubenheimer EJ, Swart TJP et al. Intraoral salivary duct carcinoma: a report of 5 cases. J Oral Maxillofac Surg. 2003;61:126–31.
3. Yilmaz F, Gı̇deroğlu K, Karaaslan K ve ark. Parotis Bezi Duktal Karsinomu: Olgu Sunumu. Düzce Tıp Fak Derg. 2008;10:64–7.
4. Simpson RHW. Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification. Head Neck Pathol. 2013;7 Suppl 1:S48-58.
5. Rajini Kanth M, Ravi Prakash A, Sreenivas PR. Salivary duct carcinoma of the minor salivary glands: A rare case report. Journal of Clinical and Diagnostic Research. 2011;5:361-63.
6. Mengi E, Kara CO, Tumkaya F et al. Salivary gland tumors: A 15-year experience. North Clin Istanb. 2020;7:366–71.
7. O. Gondak R. Salivary duct carcinoma in minor salivary glands: Report of two cases with different clinical behavior. J Clin Exp Pathol [Internet]. 2014;04(02).
8. Abdel Razek AAK, Mukherji SK. Imaging of minor salivary glands. Neuroimaging Clin N Am. 2018;28:295–302.
9. Pesce C, Colacino R, Buffa P. Duct carcinoma of the minor salivary glands: a case report. J Laryngol Otol. 1986;100:611–3.
10. Yoshimura Y, Tawara K, Yoshigi J, Nagaoka S. Concomitant salivary duct carcinoma of a minor buccal salivary gland and papillary cystadenoma lymphomatosum of a cervical lymph node. J Oral Maxillofac Surg. 1995;53:448–53.
11. Guzzo M, Di Palma S, Grandi C, Molinari R. Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck. 1997;19:126–33.
12. Cheuk W, Miliauskas JR, Chan JKC. Intraductal carcinoma of the oral cavity: A case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma. Am J Surg Pathol. 2004;28:266–70
13. Garland TA, Innes DJ Jr, Fechner RE. Salivary duct carcinoma: an analysis of four cases with review of literature. Am J Clin Pathol. 1984;81:436–41.
14. Issing WJ, Dreps A, Heppt WJ, Wustrow TP, Riederer A, Zagury JF. erbB-2/Her-2 gene amplification and overexpression in parotid gland tumors. Eur Arch Otorhinolaryngol. 1993;250:150– 3.
15. Kwon M, Roh J-L, Lee J, Cho K-J, Choi S-H, Nam SY, et al. Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma. J Craniomaxillofac Surg. 2015;43:769–78.